申请人:Universite de Montreal
公开号:US20180237457A1
公开(公告)日:2018-08-23
The present invention provides imidazopyridazine compounds or imidazothiadiazole compounds of Formula I having the structure: (I) wherein X
1
, X
2
, X
3
, X
4
, X
5
, Y, W, R
1
, R
2
, R
3
, R
4
, R
5
and (II) are as defined herein, or a stereoisomer, tautomer, pharmaceutically acceptable salt, prodrug ester or solvate form thereof. These compounds are inhibitors of platelet aggregation and thus can be used as medicaments for treating or preventing thromboembolic disorders.